Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

National Vision Holdings Inc (EYE)

National Vision Holdings Inc (EYE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,301,631
  • Shares Outstanding, K 81,424
  • Annual Sales, $ 1,712 M
  • Annual Income, $ 36,280 K
  • 60-Month Beta 1.74
  • Price/Sales 2.47
  • Price/Cash Flow 23.86
  • Price/Book 4.76
Trade EYE with:

Options Overview

Details
  • Implied Volatility 41.16%
  • Historical Volatility 16.19%
  • IV Percentile 16%
  • IV Rank 19.74%
  • IV High 80.87% on 07/28/20
  • IV Low 31.39% on 05/26/21
  • Put/Call Vol Ratio 2.11
  • Today's Volume 389
  • Volume Avg (30-Day) 63
  • Put/Call OI Ratio 2.00
  • Today's Open Interest 792
  • Open Int (30-Day) 977

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.19
  • Number of Estimates 2
  • High Estimate 0.19
  • Low Estimate 0.18
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +142.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.54 +10.58%
on 07/19/21
53.18 -1.15%
on 07/26/21
+1.72 (+3.38%)
since 06/25/21
3-Month
46.16 +13.89%
on 05/13/21
53.68 -2.07%
on 05/10/21
+1.71 (+3.36%)
since 04/26/21
52-Week
30.51 +72.30%
on 08/03/20
53.68 -2.07%
on 05/10/21
+21.24 (+67.79%)
since 07/24/20

Most Recent Stories

More News
National Vision (EYE) Banks on Partnerships Amid COVID-19 Woes

National Vision (EYE) is confident about its financial flexibility and liquidity helping it to navigate this pandemic.

TFX : 397.69 (-0.06%)
AMEH : 110.87 (-1.75%)
EYE : 52.57 (-0.49%)
NVST : 41.77 (+0.63%)
OPKO Health (OPK) Inks Licensing Deal for AntagoNAT Technology

OPKO Health's (OPK) latest licensing agreement is expected to advance the development and commercialization of potential disease-modifying therapeutics, especially for Dravet syndrome.

HZNP : 99.67 (-1.37%)
OPK : 3.57 (-1.92%)
VEEV : 328.38 (-1.41%)
EYE : 52.57 (-0.49%)
Inogen (INGN) Hits New 52-Week High: What's Driving It?

Investors are optimistic about Inogen's (INGN) direct-to-customer business model and a strong product portfolio.

AMN : 98.47 (+0.03%)
VEEV : 328.38 (-1.41%)
INGN : 72.87 (+1.62%)
EYE : 52.57 (-0.49%)
QIAGEN (QGEN) Stock Falls on Downbeat Full-Year Guidance

According to QIAGEN (QGEN), stronger-than-expected growth trends were seen in non-COVID product groups in the second quarter of 2021.

QGEN : 51.24 (-1.44%)
PETQ : 36.12 (-1.15%)
EYE : 52.57 (-0.49%)
NVST : 41.77 (+0.63%)
NuVasive (NUVA) International Sales Solid Despite COVID-19 Woes

We are upbeat about NuVasive's (NUVA) newly-introduced organizational and leadership structure for its global commercial operations as well as its product and services organization.

NUVA : 64.15 (-0.71%)
PETQ : 36.12 (-1.15%)
EYE : 52.57 (-0.49%)
NVST : 41.77 (+0.63%)
3 Stocks in Focus on Evolving MedTech Trends Amid COVID-19

Stocks like Allscripts Healthcare Solutions (MDRX), National Vision Holdings (EYE) and Quest Diagnostics (DGX) are in focus on evolving MedTech trends.

BSX : 43.97 (-0.34%)
MDT : 128.07 (-0.37%)
DGX : 138.38 (-0.75%)
BAX : 80.77 (-0.46%)
MDRX : 17.24 (-0.23%)
ALGN : 635.58 (-0.42%)
EYE : 52.57 (-0.49%)
Medtronic (MDT) Reports Economic Findings on PRODIGY Data

Medtronic (MDT)-sponsored PRODIGY Trial data was used to analyze cost benefits and outcomes from continuous pulse oximetry and capnography monitoring in high-risk patients.

MDT : 128.07 (-0.37%)
BLFS : 45.26 (-3.06%)
EYE : 52.57 (-0.49%)
NVST : 41.77 (+0.63%)
National Vision Expands Annual Continuing Education Symposium to Three Regional Events, Attracting Record Number of Optometrists

National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation's largest optical retailers providing quality, affordable eye care and eyewear, brought together more than 1,500 optometrists in its Doctor...

EYE : 52.57 (-0.49%)
BD's (BDX) Digital Marketplace Set to Improve User Experience

BD's (BDX) latest online marketplace is expected to offer a better user experience to its flow cytometry users.

BDX : 249.43 (-0.66%)
AMN : 98.47 (+0.03%)
VEEV : 328.38 (-1.41%)
EYE : 52.57 (-0.49%)
Philips (PHG)-Cognizant Collaborate to Develop Health Solutions

Philips (PHG) is collaborating with Cognizant to develop health solutions that will help healthcare and life science companies provide improved patient care and accelerate clinical trial procedure.

AMZN : 3,699.82 (+1.18%)
PHG : 46.14 (-3.75%)
CTSH : 69.43 (+0.20%)
EYE : 52.57 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

National Vision Holdings, Inc. is involved in optical retail primarily in the United States. The company offer product and services for eye care needs through retail stores and consumer websites. Its brand portfolio consists of America's Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside...

See More

Key Turning Points

3rd Resistance Point 54.19
2nd Resistance Point 53.55
1st Resistance Point 53.19
Last Price 52.57
1st Support Level 52.19
2nd Support Level 51.55
3rd Support Level 51.19

See More

52-Week High 53.68
Last Price 52.57
Fibonacci 61.8% 44.83
Fibonacci 50% 42.10
Fibonacci 38.2% 39.36
52-Week Low 30.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar